Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

30.140
+2.1607.72%
Volume:9.34M
Turnover:277.40M
Market Cap:10.67B
PE:-33.87
High:30.480
Open:28.020
Low:28.020
Close:27.980
52wk High:58.600
52wk Low:22.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:2.31
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.890
ROE:-1.18%
ROA:-1.06%
PB:1.75
PE(LYR):-33.87
PS:3.79

Loading ...

Everest Medicines Stock In Focus After China Approval For CARDAMYST

Simply Wall St.
·
Yesterday

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Stock News
·
Sep 30

Movement Alert|EVEREST MED Rises 5.72% in Regular Trading, Medical Industry Policy and mRNA Pipeline Progress Boost Sentiment

Market Focus
·
Sep 30

Everest Medicines Sets Up ESG Committee, Names Four Directors Including Chairman Yifang Wu

Bulletin Express
·
Sep 28

Everest Medicines Establishes ESG Committee to Strengthen Sustainability Governance

Bulletin Express
·
Sep 28

Everest Medicines Forms ESG Committee

Stock News
·
Sep 28

Movement Alert|EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54

Market Focus
·
Sep 24

HK Movers | Biotech Names Firmed: CANSINOBIO up Nearly 10%, JW THERAP-B up More Than 7%

Tiger Newspress
·
Sep 23

Movement Alert|EVEREST MED Rises 5.23% in Regular Trading, Weshiping Domestic Production Registration Accepted with Priority Review

Market Focus
·
Sep 23

HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%

Tiger Newspress
·
Sep 21

Movement Alert|EVEREST MED Rises 5.8% in Regular Trading, Velsipity Domestic Production Application Accepted with Priority Review

Market Focus
·
Sep 21

Movement Alert|EVEREST MED Rises 5.24% in Regular Trading, Drug Registration Application for Domestic Production Transfer of Weishiping Accepted

Market Focus
·
Sep 18

Hong Kong Stock Market Alert: EVEREST MED Surges Over 5% on Regulatory Filing Acceptance for Local Production Transfer

Stock News
·
Sep 18

Everest Medicines Chairman Wu Yifang Boosts Stake With New Share Purchase at HK$28.71 Each

Deep News
·
Sep 13

Board Chairman Acquires Additional Stake in EVEREST MED with Two-Thousand-Share Purchase

Stock News
·
Sep 11

EVEREST MED: Yifang Wu Acquires Shares, Long Position Rises to 0.62%

HK Disclosure
·
Sep 11

Movement Alert|EVEREST MED Falls 5.39% in Regular Trading, Haisen Strategic Cooperation Raises Related-Party Transaction Concerns Amid Continued Profit-Taking

Market Focus
·
Sep 11

Movement Alert|EVEREST MED Falls 5.38% in Regular Trading, Post-Approval Profit-Taking on Xingbituo Continues Amid Sector Weakness

Market Focus
·
Sep 10

Everest Medicines Unit Enters Supply, Distribution Cooperation Contract

MT Newswires Live
·
Sep 09

Everest Medicines seals strategic cooperation with Hasten; sets RMB3.08 billion 2028 cap on connected transactions

Bulletin Express
·
Sep 09